US Bancorp’s Tiziana Life Sciences TLSA Stock Holding History

US Bancorp’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$1.17K	–	4339
2026 Q1	$1.17K	Hold	1,000	–	–	﹤0.01%	3908
2025 Q4	$1.49K	Sell	1,000 -9,157	-90%	-$16.4K	﹤0.01%	3800
2025 Q3	$21.9K	Buy	+10,157	New	+$18.8K	﹤0.01%	3037
2022 Q4	–	Sell	-500	Closed	–	–	4282
2022 Q3	$0	Hold	500	–	–	﹤0.01%	4217
2022 Q2	$0	Hold	500	–	–	﹤0.01%	4229
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	4000
2021 Q4	$0	Buy	+500	New	+$663	﹤0.01%	4225

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

MAWAG

Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Bancorp's TLSA Position: Q2 2026 in Review

US Bancorp sold out of Tiziana Life Sciences (TLSA) in Q2 2026, closing a stake of 1,000 shares — an estimated $1.17K sold.

US Bancorp first reported a position in TLSA in Q4 2021 and held it in 7 quarters. The position peaked at $21.9K in Q3 2025. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

US Bancorp reported no remaining Tiziana Life Sciences position as of Q2 2026 after selling out during the quarter.
US Bancorp sold 1,000 Tiziana Life Sciences shares in Q2 2026, an estimated $1.17K.
US Bancorp first reported a position in Tiziana Life Sciences in Q4 2021 and held it in 7 quarters.
US Bancorp's Tiziana Life Sciences position peaked at $21.9K in Q3 2025.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.